CT Cardiomegaly vs Rhythm360

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

CT Cardiomegaly

by Innolitics

Rhythm360

by RhythmScience

AI Verdict

Tool A is designed for automated cardiothoracic ratio measurement from CT images to aid in cardiomegaly detection. Tool B, conversely, is an integrated platform that aggregates and analyzes cardiac monitoring data from various devices to provide insights for managing conditions like hypertension and heart failure, and to reduce alert fatigue. While both fall under Cardiology AI, Tool A focuses on diagnostic imaging analysis, whereas Tool B specializes in continuous patient monitoring and data management.

Choose CT Cardiomegaly if…

Choose CT Cardiomegaly if your primary need is automated, quantitative assessment of cardiomegaly directly from CT chest images. This FDA-cleared command-line software is ideal for radiology departments or research settings requiring objective cardiothoracic ratio measurements to assist in diagnosis and track cardiac changes, integrating seamlessly into existing imaging pipelines for efficient, standardized analysis.

View CT Cardiomegaly →

Choose Rhythm360 if…

Choose Rhythm360 if your practice requires a comprehensive, integrated platform to manage and analyze cardiac monitoring data from diverse devices and OEMs. This cloud-based SaaS solution is best for clinics seeking to reduce alert fatigue, streamline remote patient monitoring workflows, and automate billing processes through robust EHR integration and AI-driven insights for conditions like hypertension and heart failure.

View Rhythm360 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	CT Cardiomegaly	Rhythm360
Pricing	Fixed-fee	Flexible pricing model that scales with clinic size and platform usage.
Deployment	Docker Container (Ubuntu 20.04), command-line software	Cloud-based SaaS platform
BAA Available	Unknown	Yes AI-estimated
FDA Status	Cleared AI-estimated	Unknown
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Rhythm360

Tool B (Rhythm360) offers a cloud-based SaaS platform with a HIPAA-compliant mobile application for clinicians, featuring a unified dashboard and simple workflows designed to reduce alert fatigue. In contrast, Tool A (CT Cardiomegaly) is described as command-line software, suggesting a more technical interface that would require specialized IT expertise for operation.

Clinical Value

Rhythm360

Tool B (Rhythm360) provides broader clinical value by unifying diverse cardiac monitoring data to offer actionable insights for hypertension, heart failure, and rhythm management, significantly reducing alert fatigue and demonstrating a 74% reduction in hospitalizations for heart failure patients. While Tool A (CT Cardiomegaly) offers valuable quantitative data for cardiomegaly detection and is FDA-cleared, its clinical scope is narrower, focusing on a single diagnostic measurement.

Pricing & Value

Rhythm360

Tool B (Rhythm360) offers a flexible pricing model that scales with clinic size and platform usage, with documented potential for up to 300% revenue increases through automated CPT code documentation and billing, often paying for itself within months. Tool A (CT Cardiomegaly) only states 'contact for pricing,' making its value proposition less transparent and harder to quantify for potential users.

Enterprise Readiness

Rhythm360

Tool B (Rhythm360) demonstrates superior enterprise readiness with its cloud-based SaaS deployment, extensive bi-directional EHR integrations (e.g., Epic, Cerner, Athenahealth), and vendor-neutral data aggregation from all major cardiac device OEMs. Tool A (CT Cardiomegaly), while FDA-cleared and HIPAA-compliant, relies on a Docker Container and command-line interface, which may require more bespoke integration efforts within a large enterprise environment.

Innovation

Rhythm360

Tool B (Rhythm360) showcases greater innovation through its comprehensive vendor-neutral data aggregation, AI-driven alert triage that significantly reduces response times, predictive algorithms for heart failure management (including a licensed algorithm from Cedars-Sinai), and advanced AI data normalization techniques. Tool A's innovation is focused on automating a specific cardiothoracic ratio measurement, which is valuable but less broad in its application of AI across the cardiac care continuum.

Support & Docs

Rhythm360

Tool B (Rhythm360) provides robust support, including optional 24/7/365 oversight by certified cardiac technicians, a comprehensive online knowledge base, and direct contact support via a toll-free number and email. Tool A (CT Cardiomegaly) does not provide explicit information regarding product support or documentation for end-users in the provided facts or search results.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	CT Cardiomegaly	Rhythm360
Name	CT Cardiomegaly	Rhythm360
Company	Innolitics	RhythmScience
Primary Function	Automatically measures cardiothoracic ratio from CT chest images for cardiomegaly detection.	Unifies cardiac monitoring data from various devices, providing actionable insights for hypertension, heart failure, and rhythm management.
Data Input/Integration	CT chest images	Vendor-neutral data aggregation (all major OEMs), Bi-directional EHR integration, AI Data Normalization (API, HL7, XML, PDF parsing)
Output/Reporting	PDF and JSON reports (linear and area-based cardiothoracic ratios)	Actionable insights, Automated CPT code documentation and billing, HIPAA-compliant mobile application for clinicians
Target Specialties	Cardiology, Radiology	Cardiology

Videos

Demos, reviews, and walkthroughs featuring CT Cardiomegaly and Rhythm360.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary clinical application of each tool?

CT Cardiomegaly is designed to automatically measure the cardiothoracic ratio from CT chest images to assist physicians in detecting cardiomegaly with quantitative data. Rhythm360, on the other hand, is an integrated platform that unifies cardiac monitoring data from various devices to provide actionable insights for hypertension, heart failure, and rhythm management, aiming to reduce alert fatigue.

What type of patient data does each tool utilize and process?

CT Cardiomegaly processes CT chest images to perform its measurements. Rhythm360 aggregates and normalizes cardiac monitoring data from various devices, including all major OEMs like Medtronic, Boston Scientific, Abbott, and Biotronik.

Does either tool offer integration with existing Electronic Health Record (EHR) systems?

Rhythm360 offers bi-directional EHR integration with major systems such as Epic, Cerner, Athenahealth, eClinicalWorks, GreenwayHealth, and GE Centricity. CT Cardiomegaly is described as command-line software and does not explicitly mention EHR integration in its features.

What are the key outputs or actionable insights provided by each tool to assist in patient care?

CT Cardiomegaly calculates linear and area-based cardiothoracic ratios and outputs PDF and JSON reports. Rhythm360 provides AI-driven alert triage, automated CPT code documentation and billing (e.g., 93298, 93299, 99454, 99453, 99457), and predictive algorithms for heart failure management and GDMT optimization.